Clinical Trials Sponsored by Genova Inc.

Total 37613 results

Genova Inc.

Recruiting

Novaferon for COVID-19 Treatment Trial (NCTT-005)

Covid19

Japan
Genova Inc.

Recruiting

Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19 (NOVATION-1)

Covid19

Turkey, Malaysia, Brazil, Argentina, Canada, Chile, Colombia, Indonesia, Kenya, Peru, South Africa, Ukraine
Stephane Genevay
University Hospital, Geneva

Terminated

Local Injection Under US Control in GTPS.

Bursitis | Periarthritis

Switzerland
Genova Inc.
Tokyo Shinagawa Hospital

Recruiting

Novaferon in Non-hospitalized Adult Patients With Mild COVID-19

Covid19

Japan
Renovia, Inc.

Completed

Use of the Leva Incontinence System in Treating Bladder Incontinence.

Stress Urinary Incontinence

United States
Renovia, Inc.

Unknown

Use of the Leva Pelvic Digital Health System in Women With Fecal Incontinence

Fecal Incontinence

United States
Renovia, Inc.

Completed

Comparing Use of a Digital Health System of Pelvic Floor Exercise Program to Kegel Exercises in Stress Urinary Incontinence

Stress Urinary Incontinence | Mixed Urinary Incontinence

United States
Kenota Inc.

Completed

Kenota 1 CWS Method Comparison Validation Study

Allergy | Immunoglobulin E-Mediated Allergic Disorder

United States
Sonova AG
Sonova Canada Inc.

Terminated

Compression Headphone Study

Hearing Loss

Canada
Sonova AG
Sonova Canada Inc.

Completed

Validation of Novel BTE and SP Hearing Aid Models

Hearing Loss

Canada
Sonova AG
Sonova Canada Inc.

Completed

Clinical Study of Released Unitron RIC and BTE Hearing Aid Models

Hearing Loss

Canada
Sonova AG
Sonova Canada Inc.

Completed

Speech Locator In-car Performance Evaluation

Hearing Loss

Canada
University Hospital, Geneva
ModernaTX, Inc.; University of Geneva, Switzerland

Active, not recruiting

Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study (MIViral)

SARS-CoV-2 Infection | RSV Infection | Influenza Viral Infections | Virus Shedding | Mucosal Immunity

Switzerland
Genuv Inc.

Terminated

Trial of Safety, Tolerability and Efficacy of Trametinib (SNR1611) in Patients With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

Korea, Republic of
Innova Vascular, Inc.

Not yet recruiting

Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST) (TRUST)

Pulmonary Embolism
Genocea Biosciences, Inc.

Completed

Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine

Renal Cell Carcinoma | Squamous Cell Carcinoma of the Head and Neck | Non-small Cell Lung Cancer | Urothelial Carcinoma | Cutaneous Melanoma

United States
Hinova Pharmaceuticals Inc.

Completed

A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics

Metastatic Castration Resistant Prostate Cancer

China
Hinova Pharmaceuticals Inc.

Completed

A Study Evaluating Enzalutamide Pharmacokinetics and Pharmacodynamics, and Related Changes After Drug Switch

Metastatic Castration Resistant Prostate Cancer

China
Genocea Biosciences, Inc.

Completed

Evaluating New Formulation of Therapeutic HSV-2 Vaccine

Genital Herpes Simplex Type 2

United States
Genocea Biosciences, Inc.

Completed

Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pneumoniae

Pneumococcal Infections | Pneumonia, Pneumococcal

United Kingdom
Genocea Biosciences, Inc.

Completed

Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity

Genital Herpes Simplex Type 2

United States
Genocea Biosciences, Inc.

Completed

Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine

Genital Herpes Simplex Type 2

United States
Genocea Biosciences, Inc.

Completed

Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study

Genital Herpes Simplex Type 2

United States
Genocea Biosciences, Inc.

Completed

Safety and Immunogenicity Study of Prophylactic Streptococcus Pneumoniae Vaccine

Streptococcus Pneumoniae

United States
Hinova Pharmaceuticals Inc.

Recruiting

A Phase I Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients

Metastatic Castration-resistant Prostate Cancer

China
Genocea Biosciences, Inc.

Terminated

TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy

Melanoma | Renal Cell Carcinoma | Squamous Cell Carcinoma of Head and Neck | Non-small Cell Lung Cancer | Small-cell Lung Cancer | Urothelial Carcinoma | Anal Squamous Cell Carcinoma | Merkel Cell Carcinoma | Cutaneous Squamous Cell Carcinoma

United States
Genocea Biosciences, Inc.

Completed

Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine

Genital Herpes Simplex Type 2

United States
DeNova Research
Merz Aesthetics Inc.

Completed

Injectable Filler for Cheek Flattening

Malar Deficiency

United States
University Hospital, Geneva
Haute école de santé - Genève

Completed

Evaluation of a Ionic Silver and Honey Preparation to Treat Chronic Wounds of the Lower Legs

Leg Ulcer

Switzerland
Renovo Concepts, Inc.

Not yet recruiting

A Multi-center, Early Feasibility Study of Using the Mechanical Tissue Resuscitation™ (MTR™) Therapy System for Removal of Excess Fluid in Subjects Who Have Had a Portion of Their Skull Removed to Expose the Dura/Brain and Require Drainage for Fluid Removal.

Clinical Need for Craniotomy or Craniectomy
Hinova Pharmaceuticals Inc.

Recruiting

A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC).

mCRPC

China
Genocea Biosciences, Inc.

Terminated

Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection

Genital Herpes | HSV-2 Infection

United States
DeNova Research
Standard Process Inc.

Completed

A Study of Nutritional Supplementation in Altering Ecchymosis, Erythema and Health Outcomes Associated With Aesthetic Procedures

Ecchymosis and Erythema Commonly Associated With Soft Tissue Filler Injections

United States
University of Genova

Recruiting

Recovery After Intensive Care Study (RAI)

Intensive Care Unit Syndrome | Outcome | Follow up

Italy
University of Genova

Completed

Fasting-mimicking Diet in Patients Undergoing Active Cancer Treatment

Cancer | Breast Cancer | Colorectal Cancer

Italy
University of Genova

Completed

Effect of Exercise Training in Alzheimer's Patients (ExCiTE-A)

Alzheimer Disease

Italy
University of Genova

Unknown

GENOA ORAL GROWTH LONGITUDINAL STUDY (GeOrGS) (GeOrGS)

Dental Caries | Malocclusion

Italy
University of Genova

Unknown

Tomosynthesis (TS) or Ultrasound (US) in Mammography-negative Dense Breasts (TOMUS). National Multicenter Trial (TOMUS)

Breast Cancer

Italy
University of Genova

Unknown

Procedures and Follow-up of Percutaneous Tracheostomy in Intensive Care Unit

Heart Failure | Acute Respiratory Failure | Neurological Disease

Italy
University of Genova

Completed

Sublingual Immunotherapy In Alternaria-Induced Rhinitis

Allergic Rhinitis (w/w Asthma) Due to Alternaria Alternata

Italy
Human Genome Sciences Inc.

Completed

A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1

Hepatitis C, Chronic

Canada, Australia, Israel, Germany, Czech Republic, France, Poland, Romania
Human Genome Sciences Inc.

Completed

Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States, Canada, Australia, India
Human Genome Sciences Inc.

Terminated

A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01

Rheumatoid Arthritis

United States, Poland
Human Genome Sciences Inc.

Completed

Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

United States
Human Genome Sciences Inc.

Completed

Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Lymphoma, Non-Hodgkin

United States
Human Genome Sciences Inc.

Completed

A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3

Chronic Hepatitis C

Canada
Human Genome Sciences Inc.

Withdrawn

Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis

Ulcerative Colitis
DeNova Research
Merz North America, Inc.

Completed

A Double-Blinded, Randomized Placebo Controlled Pilot Study Comparing the Efficacy and Safety of IncobotulinumtoxinA Versus Saline Injections to the Cheek Region in Patients With Rosacea

Rosacea

United States
Anova Enterprises, Inc

Recruiting

AnovaOS Network Powered Patient Registry

Neoplasms | Infectious Disease | External Causes of Morbidity and Mortality | Pregnancy, Childbirth and the Puerperium | Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89) | Endocrine, Nutritional and Metabolic Diseases (E00-E89) | Mental... and other conditions

United States
University of Genova

Recruiting

Metabolic and Immunological Effects of a Modified Fasting Regimen in Cancer Patients

Cancer

Italy

Clinical Trials Sponsored by Genova Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations